Sat, Apr 19, 2014, 9:44 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Cytokinetics, Incorporated Message Board

dctrig 106 posts  |  Last Activity: Apr 17, 2014 8:28 PM Member since: Jan 26, 2006
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • dctrig dctrig Feb 3, 2014 12:16 PM Flag

    The pros know it: despite the big haircut as of 12:15PM EST, Barrons amazingly shows 1.29 ACCUMULATION and $45,895 positive net money flow into ETRM.

  • Look, months ago the FDA gave ETRM an estimated ADCOM date; however, the threathened govt shutdown last fall put the FDA out of synch.

  • Reply to

    $1.99 Close So Predictable

    by dctrig Jan 30, 2014 4:02 PM
    dctrig dctrig Jan 30, 2014 4:16 PM Flag

    21K @ about 1.80 avg.

  • Reply to

    $1.99 Close So Predictable

    by dctrig Jan 30, 2014 4:02 PM
    dctrig dctrig Jan 30, 2014 4:07 PM Flag

    The insanity of the market is shown by the sheep who paid 3X the IPO price for Dicerna today.

  • In the last 10 minutes I knew it would close at $1.99; no way the NASDAQ was going to let a $2 trade go through.

  • Reply to

    Time to buy

    by tipsmaster Jan 30, 2014 9:25 AM
    dctrig dctrig Jan 30, 2014 3:51 PM Flag

    Those who got scared and sold today will be kicking themselves when the ADCOM announcement came. They sold their farmland to geologists who knew the true value.

  • When the stock went above $2 many brokers allowed margin purchases and I think some bought on margin. Also, stops(rarely a good idea) are being taken out.

  • Reply to

    Time to buy

    by tipsmaster Jan 30, 2014 9:25 AM
    dctrig dctrig Jan 30, 2014 2:53 PM Flag

    This is a programmed shakeout. Barrons still shows accumulation.

  • Reply to

    Time to buy

    by tipsmaster Jan 30, 2014 9:25 AM
    dctrig dctrig Jan 30, 2014 12:31 PM Flag

    Currently down 7 cents yet Barrons shows 1.45 positive uptick and over 69K positive money flow into ETRM. This may be last call befor a news catalysts. Those on the sidelines who don't buy will regret the long timeline the market gifted them to make a decision.

  • Reply to

    Time to buy

    by tipsmaster Jan 30, 2014 9:25 AM
    dctrig dctrig Jan 30, 2014 11:34 AM Flag

    Many retail traders still do not understand that you can have a sustained price decline ON ACCUMULATION. The super computers at HFT desks like Citadel in Chicago have awesome micro-second capabilities. Barrons today shows 1.39 positive uptick and $32,000 net money flow into ETRM.

  • dctrig dctrig Jan 30, 2014 10:17 AM Flag

    (CSII is also in St Paul and is flying today on great sales. The FDA is seriously concerned about cardiovascular disease and approval of VBLOC is virtually a lock).

    Cardiovascular Systems, Inc. (CSI) (CSII), today announced that physician demand continues to build
    throughout the United States for its recently approved Diamondback 360® Coronary Orbital Atherectomy System (OAS). The system is the first and only technology approved for the treatment of severely calcified coronary lesions, and the only new FDA-approved coronary atherectomy device in more than two decades.

    Said Dr. Rohit Bhatheja, Interventional Cardiologist, Florida Hospital, Orlando, Fla., a physician who recently treated his first case with the Diamondback 360 Coronary OAS: “Calcium in coronary arteries often goes undetected and even more, is left untreated because of its complexity. CSI’s OAS enables physicians to easily treat severely calcified vessels, and allows for successful stent deployment.”

    Significant arterial calcium is present in nearly 40 percent of patients undergoing a percutaneous coronary intervention, and contributes to poor outcomes and higher treatment costs in coronary interventions when traditional therapies are used—including a substantially higher occurrence of death and major adverse cardiac events.

    Commented Dr. Georges Nseir, Invasive Cardiologist, Chandler Regional Medical Center, Chandler, Ariz., “I am pleased there is a new technology available to treat the challenges of severely calcified coronary lesions. Clinical data shows that the Diamondback 360 device can help patients with severe coronary calcium, a tough-to-treat patient population. I appreciate having a proven and easy-to-use new technology.”

  • (VBLOC passes with flying colors)
    A joint panel of FDA advisors will meet next month to discuss the cardiovascular (CV) thromboembolic risks of non-steroidal anti-inflammatory drugs (NSAIDs). The joint meeting of the agency’s Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee will is scheduled for Feb. 10-11 at the FDA’s White Oak, Md., campus.
    A 2005 meeting of advisors concluded that both COX-2 selective NSAIDs and nonselective NSAIDs held potential risks but no decision was reached as to which held the greater threat.
    The February meeting will discuss literature published since, with a specific focus on:
    •Whether the data show that naproxen has a lower CV thromboembolic risk compared to other nonselective NSAIDs and what this might mean for physicians;
    •Whether the published findings indicate a differential risk for non-naproxen NSAIDs;
    •Whether there is likely to be a latency period for increased risk for NSAIDs;
    •Whether there should be restrictions or specific warnings for higher-risk patients;
    •Whether NSAIDs should remain OTC in light of new findings; and
    •Whether the Precision trial should be altered in accordance with recent literature.
    Some of the NSAIDs in question are Pfizer’s Bextra (valdecoxib) and Celebrex (celecoxib).

  • Every time in the last 2-1/2 months when ETRM has closed UNCHANGED for one or two days there has been a positive price spike: 12/18 & 12/19/13, unchanged and then a 10.5% spike the following day. 12/30 &12/31/13 two unchanged days and then a 7.1% spike. 1/7/14, UNCHANGED and then a .6% spike. Today's ultra low volume could be the lull before the storm.

  • Reply to

    How long will this "correction" last

    by russellhtayler Jan 27, 2014 4:06 PM
    dctrig dctrig Jan 28, 2014 4:18 PM Flag

    Per Barrons, Tues, 1/28 there was a continued 4 cent "correction", but on accumulation of $54,446 and a 1.2 uptick vs. downtick ratio. My 6000 share purchase recently is down $180; however, that's a mild risk vs. a possible $6000 to $30,000 profit.

  • Reply to

    FDA Now Posting March ADCOMs!

    by dctrig Jan 23, 2014 2:05 PM
    dctrig dctrig Jan 28, 2014 3:10 PM Flag

    Folks, anyone on the sidelines considering buying ETRM should get in NOW. The stock's price action is following a classic trend of a temporary price decline before a big announcement. ETRM has tons of experience dealing with EMEA and Australian regulatory authorities. They have given the FDA all the data it wanted for a promised ADCOM meeting, almost certainly in March.

  • Reply to

    Wells Fargo Capital Mgmt Just Filed

    by dctrig Jan 27, 2014 2:39 PM
    dctrig dctrig Jan 27, 2014 5:14 PM Flag

    innsbrooklad: I wonder where the 9/30/13 figure is arrived at as institutional investors are only required to file an annual SC 13G, unless there is a material change in 5% ownership. Why doesn't the SEC require quarterly filings?

  • Reply to

    How long will this "correction" last

    by russellhtayler Jan 27, 2014 4:06 PM
    dctrig dctrig Jan 27, 2014 4:16 PM Flag

    If you have a few grand you can get a telephone interview with a University of Chicago mathematician who will befuddle you with high level statistics, algorithms, probabilities, etc. Hedge funds and HFT desks don't pay seven figure salaries and bonuses to the cream of UC math grads for the fun of it.

  • 12/31/12, they owned 2,126,468 shares of ETRM; as of 12/31/13 they owned 3,214,237 shares.

  • Reply to

    Stock Price Falling?

    by jdeboer Jan 27, 2014 11:13 AM
    dctrig dctrig Jan 27, 2014 1:37 PM Flag

    JD: Today nearly all small biotechs and medical device companies are getting hit hard. Many retail traders forget that high frequency trading desks and hedge funds use extremely complex algorithms to simultaneously trade a bunch of stocks. Their game is to make small profits on as many trades as feasible. For example, Citadel out of Chicago made over 1 billion dollars in trading profit in 2013.

  • Reply to

    I Just Added 6000 shares @ 2.1688

    by dctrig Jan 24, 2014 2:29 PM
    dctrig dctrig Jan 24, 2014 4:19 PM Flag

    Barrons actually showed $9844 positive money flow today and 1.02 positive uptick vs. downtick ratio. I think there were quite a few of us buying on the dip today.

CYTK
9.52+0.45(+4.96%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
AsiaInfo-Linkage, Inc.
NasdaqGSWed, Jan 15, 2014 4:00 PM EST